FHLC
Fidelity MSCI Health Care Index ETF · PSE
- Category Equity
- Expense Ratio 0.08%
- Listing Date Oct 24, 2013
- Volume 88,703.0
- Market Cap (AUM) $3,099.6M
Performance
+1.91%
1W
+5.4%
1M
+0.49%
3M
+15.28%
6M
+6.85%
YTD
+12.03%
1Y
Top Holdings
Technical Analysis of FHLC 2024-05-10
Overview:
In analyzing the technical indicators for FHLC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysi...
Recent News & Updates
- 2024-01-04 12:00
- 2020-01-23 22:05
What Lies Ahead for Healthcare ETFs in Q4 Earnings?(Yahoo Finance)
- 2019-10-20 23:00
What's in Store for Healthcare ETFs in Q3 Earnings?(Yahoo Finance)
- 2019-09-05 03:36
6 Best Health Care Funds for a Volatile Market(Yahoo Finance)
- 2019-07-22 16:45
Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy(Yahoo Finance)
- 2019-07-21 22:55
Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy(Yahoo Finance)
- 2019-04-17 22:59
Can Q1 Earnings Lift Healthcare ETFs Higher?(Yahoo Finance)
- 2019-03-04 23:04
The 7 Best Healthcare ETFs for a Sector Rebound(Yahoo Finance)
- 2019-01-23 21:59
Healthcare ETFs in Focus Ahead of Q4 Earnings(Yahoo Finance)
- 2018-12-27 20:27
Healthcare and Value: 2 ETFs to Watch on Outsized Volume(Yahoo Finance)
- 2018-10-02 03:15
The 7 Best ETFs of the Third Quarter(Yahoo Finance)
- 2018-08-13 18:00
- 2018-08-03 03:27
- 2018-04-17 05:02
Tech Advances Could Help Healthcare ETFs Grow(Yahoo Finance)
- 2018-04-16 23:49
7 Sector ETFs to Own Now(Yahoo Finance)
- 2018-04-03 02:59
Fidelity Trims Fees on 3 Bond ETFs(Yahoo Finance)
- 2018-03-12 03:54
Market Correction May Foreshadow Bullish Run for Stock ETFs(Yahoo Finance)
- 2017-11-05 20:02
The 4 Most Promising ETFs for 2017 (XLF, FHLC)(Investopedia)
- 2017-10-24 04:09
What Analysts Recommend for Merck ahead of 3Q17 Earnings(Marketrealist)
- 2017-09-12 19:37
Must-Know Recent Developments for Gilead(Marketrealist)
- 2017-09-07 22:37
Inside Mercks Segment-Wise Performance in 2Q17(Marketrealist)
- 2017-08-31 04:36
Eli Lilly & Co.s Revenues in 2Q17(Marketrealist)
- 2017-08-29 04:35
Bristol-Myers Squibbs Oncology Products in 2Q17(Marketrealist)
- 2017-08-28 22:39
Johnson & Johnsons Consumer Segment in 2Q17(Marketrealist)
- 2017-08-22 19:37
How Allergans International Segment Performed in 2Q17(Marketrealist)
- 2017-08-14 19:36
Pfizers Declining-Revenue Products in 2Q17(Marketrealist)
- 2017-07-31 22:36
Eli Lillys Major Developments in 2Q17(Marketrealist)
- 2017-07-31 19:41
Pfizer on the Street: Analyst Recommendations after 2Q17(Marketrealist)
- 2017-07-26 06:06
Analysts Recommendations for Bristol-Myers Squibb in 2Q17(Marketrealist)
- 2017-07-23 22:11
Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs(Yahoo Finance)
- 2017-07-23 21:08
Johnson & Johnson: Medical Devices in 2Q17(Marketrealist)
- 2017-07-18 23:55
J&J Brightens Outlook: Healthcare ETFs in Focus(Yahoo Finance)
- 2017-07-16 21:07
Johnson & Johnsons 2Q17 Estimates: Medical Devices(Marketrealist)
- 2017-07-09 19:39
How 2Q17 Is Shaping Up for Pfizer(Marketrealist)
- 2017-07-03 21:08
Johnson & Johnsons Segment-Wise Performance in 1Q17(Marketrealist)
- 2017-07-02 19:38
Merck & Co. Reported 1% Growth in Its 1Q17 Revenues(Marketrealist)
- 2017-06-26 19:38
Tanezumab Receives FDA Fast Track Designation(Marketrealist)
- 2017-06-20 03:36
Updates on the Adcetris and Opdivo Combination(Marketrealist)
- 2017-06-18 19:36
How Eli Lillys Taltz Performed in Clinical Trials(Marketrealist)
- 2017-06-12 19:36
Akcea Therapeutics Volanesorsen: 1Q17 Performance(Marketrealist)
Page 1 of 3
previousnext